APGE
Price
$40.82
Change
-$0.82 (-1.97%)
Updated
Jul 25 closing price
Capitalization
2.38B
36 days until earnings call
GENFF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Jul 24 closing price
Capitalization
5.08M
Interact to see
Advertisement

APGE vs GENFF

Header iconAPGE vs GENFF Comparison
Open Charts APGE vs GENFFBanner chart's image
Apogee Therapeutics
Price$40.82
Change-$0.82 (-1.97%)
Volume$600.26K
Capitalization2.38B
Genflow Biosciences
Price$0.01
Change-$0.00 (-0.00%)
Volume$1K
Capitalization5.08M
APGE vs GENFF Comparison Chart in %
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. GENFF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and GENFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (APGE: $40.82 vs. GENFF: $0.01)
Brand notoriety: APGE and GENFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 62% vs. GENFF: 2%
Market capitalization -- APGE: $2.38B vs. GENFF: $5.08M
APGE [@Biotechnology] is valued at $2.38B. GENFF’s [@Biotechnology] market capitalization is $5.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileGENFF’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • GENFF’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than GENFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 5 TA indicator(s) are bullish while GENFF’s TA Score has 3 bullish TA indicator(s).

  • APGE’s TA Score: 5 bullish, 5 bearish.
  • GENFF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, APGE is a better buy in the short-term than GENFF.

Price Growth

APGE (@Biotechnology) experienced а +3.84% price change this week, while GENFF (@Biotechnology) price change was +33.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

APGE is expected to report earnings on Sep 01, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.38B) has a higher market cap than GENFF($5.08M). APGE YTD gains are higher at: -9.890 vs. GENFF (-77.944).
APGEGENFFAPGE / GENFF
Capitalization2.38B5.08M46,841%
EBITDA-241.42MN/A-
Gain YTD-9.890-77.94413%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash513MN/A-
Total Debt11.8MN/A-
TECHNICAL ANALYSIS
Technical Analysis
APGEGENFF
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
44%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
44%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
43%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 19 days ago
75%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
25%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USCAX13.370.09
+0.68%
Victory Small Cap Stock
DREVX20.230.13
+0.65%
BNY Mellon Large Cap Securities Inc
EMACX14.000.01
+0.07%
Gabelli Entpr Mergers & Acquisitions C
RRITX21.99-0.04
-0.18%
T. Rowe Price International Stock R
SLAPX28.53-0.20
-0.70%
DWS Latin America Equity C

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-1.97%
SYRE - APGE
53%
Loosely correlated
+1.08%
CRNX - APGE
49%
Loosely correlated
N/A
ERAS - APGE
48%
Loosely correlated
+1.75%
KRYS - APGE
48%
Loosely correlated
-1.59%
IDYA - APGE
48%
Loosely correlated
-1.33%
More

GENFF and

Correlation & Price change

A.I.dvisor tells us that GENFF and TOVX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENFF and TOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENFF
1D Price
Change %
GENFF100%
N/A
TOVX - GENFF
25%
Poorly correlated
+1.24%
VRCA - GENFF
23%
Poorly correlated
-5.57%
SGMT - GENFF
10%
Poorly correlated
+0.39%
OCS - GENFF
6%
Poorly correlated
+0.34%
APGE - GENFF
3%
Poorly correlated
-1.97%
More